---
schema_version: "secwatch.filing_event.v1"
accession: "0000313143-26-000095"
form_type: "8-K"
ticker: "HAE"
cik: "0000313143"
company_name: "HAEMONETICS CORP"
filed_at: "2026-07-28T20:28:06+00:00"
generated_at: "2026-07-28T20:29:14.606039+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Haemonetics elects Martin Madaus to board; shareholders approve additional LTIP shares

## Summary
- Martin Madaus elected to board effective July 24, 2026; will serve on Audit and Governance Committees.
- Shareholders approved amendment to 2019 LTIP, authorizing 4,680,000 additional shares and extending term to 2036.
- Shareholders approved amendment to ESPP, extending term to 2036.
- Advisory vote on executive compensation passed with 93.5% of votes cast in favor (39.2M for, 0.57M against).
- All eight director nominees elected; Christopher A. Simon received 39.7M votes for.

## SEC filing metadata
- accession: 0000313143-26-000095
- form_type: 8-K
- ticker: HAE
- cik: 0000313143
- company_name: HAEMONETICS CORP
- filed_at: 2026-07-28T20:28:06+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/313143/000031314326000095/0000313143-26-000095-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/313143/000031314326000095/hae-20260724.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000313143-26-000095
- JSON: https://secwatch.observer/filing/0000313143-26-000095.json
- Plain text: https://secwatch.observer/filing/0000313143-26-000095.txt

## Key facts
- Executive change
  Martin Madaus was elected as Director at HAEMONETICS CORP.
  - Action: elected
  - Role: Director
  source text: On July 24, 2026, the Board of Directors of Haemonetics Corporation (the “Company”) elected Martin Madaus as a director of the Company, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/313143/000031314326000095/0000313143-26-000095-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.